TY - JOUR
T1 - Advanced tissue characterization in non-ischemic cardiomyopathies using contrast-enhanced cardiac magnetic resonance imaging
AU - Shehab, Abdullah M.
AU - Strohm, Oliver
PY - 2010/2
Y1 - 2010/2
N2 - Cardio-vascular magnetic resonance imaging (CMR) can be used to obtain integrated information on both cardiac function and on advanced tissue characteristics. Using contrast-enhanced techniques, highly diagnostic information on tissue viability, inflammatory changes, and on storage diseases can be obtained within a 45-minute examination. The combination of functional information (using steady-state free precession sequences cine techniques), assessment of myocardial edema (using T2-based techniques), of reversible injury (for example in inflammatory diseases; using T 1-based techniques), and irreversible injury (for example in infarction and regional fibrosis, using late gadolinium enhancement techniques) allows disease-specific and prognostic information to be obtained in patients with non-ischemic cardiomyopathy. Contrast-enhanced CMR allows the accurate diagnosis of non-ischemic cardiomyopathies, identification of primary and secondary cardiomyopathies, and can be used to guide therapy, thus avoiding the need for invasive measures such as endomyocardial biopsy in many cases.
AB - Cardio-vascular magnetic resonance imaging (CMR) can be used to obtain integrated information on both cardiac function and on advanced tissue characteristics. Using contrast-enhanced techniques, highly diagnostic information on tissue viability, inflammatory changes, and on storage diseases can be obtained within a 45-minute examination. The combination of functional information (using steady-state free precession sequences cine techniques), assessment of myocardial edema (using T2-based techniques), of reversible injury (for example in inflammatory diseases; using T 1-based techniques), and irreversible injury (for example in infarction and regional fibrosis, using late gadolinium enhancement techniques) allows disease-specific and prognostic information to be obtained in patients with non-ischemic cardiomyopathy. Contrast-enhanced CMR allows the accurate diagnosis of non-ischemic cardiomyopathies, identification of primary and secondary cardiomyopathies, and can be used to guide therapy, thus avoiding the need for invasive measures such as endomyocardial biopsy in many cases.
UR - http://www.scopus.com/inward/record.url?scp=77949528532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949528532&partnerID=8YFLogxK
M3 - Review article
C2 - 20174724
AN - SCOPUS:77949528532
SN - 0379-5284
VL - 31
SP - 115
EP - 122
JO - Saudi Medical Journal
JF - Saudi Medical Journal
IS - 2
ER -